EurFMT (@eurfmt) 's Twitter Profile
EurFMT

@eurfmt

EurFMT = European Fecal Microbiota Transplantation Network

Do you want to be part of the #EurFMT network? Just send us a message!

ID: 1536447829778087936

calendar_today13-06-2022 20:39:38

151 Tweet

381 Followers

145 Following

Alexander Link (@alinkmd) 's Twitter Profile Photo

#WhatsNewOnFMT #ECCO24 FMT in UC ➡️ RESTORE-UC trial randomised controlled trial = stopped for futility! Allogenic FMT (n=30) Autologous FMT (n=36) 10% vs. 13% response rate! Primary response was associated with lower Mayo score! doi.org/10.1093/ecco-j…

#WhatsNewOnFMT #ECCO24 
FMT in UC ➡️ RESTORE-UC trial
randomised controlled trial = stopped for futility!

Allogenic FMT (n=30)
Autologous FMT (n=36)

10% vs. 13% response rate!

Primary response was associated with lower Mayo score!

doi.org/10.1093/ecco-j…
Ed Kuijper (@edkuijper2) 's Twitter Profile Photo

rdcu.be/dzX6K ; Studying 87 patients, FMT induced changes in the recipient resistome associated with a reduction in the abundance of Enterobacterales. However, specific recipient-ARGs persisted mainly located on plasmids. EurFMT Wiep Klaas Smits Nicolas Benech

Alexander Link (@alinkmd) 's Twitter Profile Photo

#WhatsNewOnFMT #ChronicPouchitis Meta-analysis ➡️ high heterogeneity among studies and still limited evidence for the use in clinical practice. 👉Need for randomized placebo-controlled trials! doi.org/10.1093/ecco-j… EurFMT

#WhatsNewOnFMT
#ChronicPouchitis

Meta-analysis ➡️ high heterogeneity among studies and still limited evidence for the use in clinical practice.

👉Need for randomized placebo-controlled trials!

doi.org/10.1093/ecco-j… <a href="/EurFmt/">EurFMT</a>
EurFMT (@eurfmt) 's Twitter Profile Photo

Follow our #EurFMT newsletter! Issue No. 5, March 2024 The regulatory landscape that frames microbiome therapies in Europe is evolving, and clinical data emerge. Here is your quarterly update on intestinal microbiota for therapeutic application. 👉mailchi.mp/beb584558436/e…

Follow our #EurFMT newsletter! 
Issue No. 5, March 2024  

The regulatory landscape that frames microbiome therapies in Europe is evolving, and clinical data emerge. Here is your quarterly update on intestinal microbiota for therapeutic application.  

👉mailchi.mp/beb584558436/e…
Alexander Link (@alinkmd) 's Twitter Profile Photo

"Wine matures with age" 👉but what about Faeces? ... may be in relation to immunotherapy effectivity... ➡️Older cancer patients show enhanced response to immunotherapy ➡️Aging-enriched enterotypes correlate with improved outcomes in ICB treatment, and #FMT enhances response to

"Wine matures with age"
👉but what about Faeces? ... may be in relation to immunotherapy effectivity...

➡️Older cancer patients show enhanced response to immunotherapy
➡️Aging-enriched enterotypes correlate with improved outcomes in ICB treatment, and #FMT enhances response to
Alexander Link (@alinkmd) 's Twitter Profile Photo

#WhatsNewOnFMT What is the role of bezlotoxumab in #FMT for C.difficile in #IBD patients? No benefit, but likely with more patients included/power it is possible that bezlotoxumab would even reduce efficacy and be associated with a higher rate of recurrence... 👉So if you are

Alexander Link (@alinkmd) 's Twitter Profile Photo

#WhatsNewOnFMT Mixed donor FMT vs. single donor FMT mFMT: 13.2% achieved ≥10% weight loss sFMT: 0% achieved ≥10% weight loss ✔️Mixed-donor FMT was associated with increased butyrate-producing bacteria for obesity gut.bmj.com/content/73/5/8… Siew Ng Francis Chan MD Gut Journal

Alexander Link (@alinkmd) 's Twitter Profile Photo

Don't forget to submit your abstract for the annual meeting of the European Helicobacter and Microbiota Socienty Group #EHMSG! ⌛️Deadline: 6 May 2024! 👉workshop.ehmsg.org

Don't forget to submit your abstract for the annual meeting of the European Helicobacter and Microbiota Socienty Group #EHMSG!

⌛️Deadline: 6 May 2024!

👉workshop.ehmsg.org
Harry Sokol (@h_sokol) 's Twitter Profile Photo

Fecal microbiota transplantation for recurrent C. difficile infection can be the best therapeutic option in severely immunocompromised patients depending on a case-by-case assessment of the benefit/risk ratio ⁦Gastroenterology⁩ sciencedirect.com/science/articl…

Wiep Klaas Smits (@smitslab) 's Twitter Profile Photo

New review alert: Fecal microbiota transplantation: current challenges and future landscapes journals.asm.org/doi/10.1128/cm… - thanks to Babak Yadegar and Dina Kao for bringing this work to completion! CC Ed Kuijper Gianluca Ianiro EurFMT Giovanni Cammarota Tanya Monaghan

EurFMT (@eurfmt) 's Twitter Profile Photo

Today, 13.05.2024, the first virtual general assembly of the EurFMT meeting 👉Current status 👉Ongoing projects/applications 👉Invited Interaction with Industry 👉New EU FMT regulations (SoHo) Really excellent interaction and discussion!

Alexander Link (@alinkmd) 's Twitter Profile Photo

#WhatsNewOnFMT in #LiverCirrhosis Phase 2 data on FMT in patients with hepatic encephalopathy 👉Recurrence of HE was significantly lower with FMT compared to placebo 👉Reduced hospitalization rate 👉Donor-independent effect 👉Oral vs. enema vs. both = similar effect Excellent

#WhatsNewOnFMT in #LiverCirrhosis 
Phase 2 data on FMT in patients with hepatic encephalopathy

👉Recurrence of HE was significantly lower with FMT compared to placebo
👉Reduced hospitalization rate
👉Donor-independent effect
👉Oral vs. enema vs. both = similar effect

Excellent
Lindsey Ann Edwards (@drlaedwards) 's Twitter Profile Photo

Excited to present our data @ #IHMC2024 on FMT to tackle #AMR in cirrhosis, we see restoration of gut barrier function/immunity, immunometabolisim & with collaboration with Phase Genomics we see beneficial bacteriophage remodelling !

Excited to present our data @ #IHMC2024 on FMT to tackle #AMR in cirrhosis, we see restoration of gut barrier function/immunity, immunometabolisim &amp; with collaboration with <a href="/PhaseGenomics/">Phase Genomics</a> we see beneficial bacteriophage remodelling !
Alexander Link (@alinkmd) 's Twitter Profile Photo

#WhatsNewOnFMT in children with constipation Randomized, double-blind, controlled trial Enema+Placebo vs. Enema +FMT ✅FMT enhances the efficacy of colonic enema and the use of enema-based FMT is a safe and effective method in the treatment of intractable constipation in

#WhatsNewOnFMT in children with constipation

Randomized, double-blind, controlled trial
Enema+Placebo vs. Enema +FMT

✅FMT enhances the efficacy of colonic enema and the use of enema-based FMT is a safe and effective method in the treatment of intractable constipation in
Alexander Link (@alinkmd) 's Twitter Profile Photo

Join us at the 37th Workshop of the European Helicobacter and Microbiota Study Group (#EHMSG) held in Porto, Portugal on September 12 - 14, 2024 workshop.ehmsg.org/registration

Join us at the 37th Workshop of the European Helicobacter and Microbiota Study Group (#EHMSG) held in Porto, Portugal on September 12 - 14, 2024

workshop.ehmsg.org/registration
EurFMT (@eurfmt) 's Twitter Profile Photo

4th General Assembly #EurFMT October 12, 2024 in Vienna Topic: FMT landscape in EU, SoHo regulation etc. If you are interested in attending the meeting - there are only a few places left! Please use the email pre-registration 👇!

4th General Assembly #EurFMT
October 12, 2024 in Vienna

Topic: FMT landscape in EU, SoHo regulation etc.

If you are interested in attending the meeting - there are only a few places left!
Please use the email pre-registration 👇!
Alexander Link (@alinkmd) 's Twitter Profile Photo

EHMSG - an excellent opportunity for interaction and networking on microbiota, FMT, Helicobacter infection, gastric cancer and much more! It was great to catch up with friends and colleagues in Porto!

EHMSG - an excellent opportunity for interaction and networking on microbiota, FMT, Helicobacter infection, gastric cancer and much more! 

It was great to catch up with friends and colleagues in Porto!
EurFMT (@eurfmt) 's Twitter Profile Photo

Amazing to see such a great participation and interaction at the #EurFMT General Assembly in Vienna during #UEGWeek 2024!